Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.51 Insider Own6.75% Shs Outstand18.05M Perf Week-31.75%
Market Cap23.28M Forward P/E- EPS next Y-1.10 Insider Trans2.52% Shs Float16.83M Perf Month-48.40%
Income-21.14M PEG- EPS next Q-0.26 Inst Own10.35% Short Float0.48% Perf Quarter-70.48%
Sales0.00M P/S- EPS this Y38.95% Inst Trans8.29% Short Ratio0.39 Perf Half Y-49.61%
Book/sh0.48 P/B2.69 EPS next Y-5.36% ROA-117.80% Short Interest0.08M Perf Year-73.01%
Cash/sh0.70 P/C1.84 EPS next 5Y- ROE-177.83% 52W Range1.20 - 5.33 Perf YTD-60.49%
Dividend Est.- P/FCF- EPS past 5Y-79.01% ROI-229.42% 52W High-75.80% Beta0.34
Dividend TTM- Quick Ratio2.77 Sales past 5Y93.18% Gross Margin-51.47% 52W Low7.50% ATR (14)0.27
Dividend Ex-Date- Current Ratio2.77 EPS Y/Y TTM7.85% Oper. Margin0.00% RSI (14)25.55 Volatility10.17% 11.77%
Employees32 Debt/Eq0.10 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price8.80
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q48.12% Payout- Rel Volume1.82 Prev Close1.30
Sales Surprise-100.00% EPS Surprise29.21% Sales Q/Q-100.00% EarningsMay 14 BMO Avg Volume207.17K Price1.29
SMA20-39.68% SMA50-50.46% SMA200-60.24% Trades Volume377,624 Change-0.77%
Date Action Analyst Rating Change Price Target Change
Apr-12-21Initiated Oppenheimer Outperform $30
Apr-12-21Initiated BTIG Research Buy $30
Jun-14-24 08:37AM
Jun-13-24 09:00PM
May-30-24 07:00AM
01:54PM Loading…
May-14-24 01:54PM
May-03-24 10:00AM
Apr-24-24 09:25AM
Apr-17-24 09:55AM
Apr-10-24 03:30PM
Apr-08-24 09:25AM
Apr-02-24 05:40PM
Apr-01-24 07:01PM
09:25AM Loading…
Mar-26-24 01:53PM
Mar-15-24 02:30PM
Mar-05-24 09:45AM
Feb-27-24 02:00PM
Feb-14-24 12:29PM
Feb-06-24 09:56AM
Jan-31-24 08:00AM
Jan-24-24 12:00PM
Jan-02-24 08:00AM
Dec-14-23 09:55AM
Dec-04-23 08:00AM
08:00AM Loading…
Dec-01-23 08:00AM
Nov-29-23 08:00AM
Nov-24-23 01:01PM
Nov-22-23 11:58AM
Nov-21-23 08:54AM
Nov-20-23 04:03PM
Nov-14-23 07:00AM
Oct-04-23 08:45AM
Sep-25-23 04:05PM
Sep-20-23 04:05PM
Sep-12-23 09:25AM
Aug-29-23 08:57AM
Aug-28-23 07:00AM
Aug-10-23 08:25AM
Aug-07-23 07:00AM
Jul-31-23 08:00AM
Jun-01-23 08:00AM
May-13-23 08:09AM
May-12-23 09:15AM
May-08-23 10:00AM
May-03-23 09:15AM
Apr-12-23 04:30PM
Mar-29-23 08:52AM
Mar-23-23 04:05PM
Mar-22-23 08:30AM
Mar-21-23 08:00AM
Mar-09-23 08:00AM
Feb-27-23 08:00AM
Feb-02-23 08:00AM
Jan-17-23 10:00AM
Jan-12-23 04:05PM
Nov-10-22 05:15PM
Sep-26-22 11:59AM
Sep-20-22 07:30AM
Sep-19-22 08:00AM
Sep-08-22 08:00AM
Sep-06-22 08:00AM
Aug-08-22 09:15AM
Aug-04-22 08:00AM
Aug-03-22 10:00AM
Jun-02-22 08:00AM
May-18-22 08:00AM
May-16-22 05:55PM
May-11-22 09:30AM
May-06-22 08:00AM
May-03-22 08:31AM
May-02-22 03:00PM
Apr-26-22 05:19PM
Apr-12-22 01:00PM
Mar-29-22 08:00AM
Mar-24-22 08:00AM
Mar-15-22 08:00AM
Mar-01-22 08:00AM
Feb-08-22 08:00AM
Feb-04-22 12:06PM
Jan-31-22 04:05PM
Jan-18-22 08:00AM
Jan-06-22 04:05PM
Dec-28-21 04:05PM
Dec-16-21 06:57AM
Dec-07-21 08:00AM
Dec-01-21 04:07PM
Nov-12-21 09:52AM
Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never before targeted. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. The firm is also unlocking new treatment options to treat disorders characterized by protein misfolding. The company was founded by Khalid Islam in 2017 and is headquartered in Bethesda, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Riley Jeffrey ScottDirectorMar 28 '24Buy3.8630,000115,77030,000Apr 01 04:01 PM
Alder MatthiasChief Executive OfficerDec 21 '23Sale2.462065075,286Dec 22 04:17 PM
Alder MatthiasChief Executive OfficerDec 07 '23Sale2.501,8204,5504,855Dec 14 04:01 PM